SAN DIEGO - Reuters reports that Illumina has signed a $17 million contract to provide the U.S. Food and Drug Administration with its MiSeq DNA sequencer to help the FDA track food-related pathogen outbreaks.
The agency will use MiSeq for whole genome analysis on products and samples of Salmonella and E. coli, according to Reuters.
Retuers notes that this deal comes just two weeks after the Center For Food Safety filed suit against FDA for alleged failure to fully enforce the Food Safety and Modernization Act.
Read the full report at Reuters.
(Source: Reuters)
Latest from Quality Assurance & Food Safety
- USDA Indefinitely Delays Salmonella Testing Program for Raw Breaded Stuffed Chicken
- American Soybean Association Names New Industry Relations Leadership
- Babybel Transitions From Cellophane to Paper Packaging
- Ambriola Company Recalls Cheese Products Due to Listeria Risk
- Horizon Family Brands Acquires Maple Hill Creamery
- Kellanova Shares Top Five Consumer Packaged Goods Tech Trends Shaping 2026
- Stay Ahead of Supply Chain Pressure
- Brendan Niemira Named IFT Chief Science and Technology Officer
